You are here: Industry Insights > Biocon Biologics

News List

Biocon Biologics and Viatris receive US FDA approval for maiden interchangeable biosimilar Semglee expresspharma
July 30, 2021
Interchangeable designation allows substitution at the pharmacy counter for Lantus across the US to help increase access to medicines for people living with diabetes.
Biocon Biologics, Viatris get EC approval for biosimilar Bevacizumab expresspharma
April 27, 2021
Abevmy 100 and 400 mg is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen.
Biocon Biologics appoints susheel Umesh as chief commercial officer for emerging mkts expresspharma
March 03, 2021
Biocon Biologics announced that Susheel Umesh has joined Biocon Biologics as the Chief Commercial Officer- Emerging Markets from March 1, 2021.
Biocon Biologics promotes Shreehas Tambe to deputy chief executive officer expresspharma
March 02, 2021
Biocon Biologics announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon Biologics w.e.f. March 1, 2021.
Biocon Biologics and Viatris get CHMP Nod for Abevmy expresspharma
March 01, 2021
Biocon Biologics, a subsidiary of Biocon announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authoris ation of their biosimilar Bevacizumab ...
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries expresspharma
February 05, 2021
Biocon has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership (CAP).
Biocon Biologics inducts Professor Peter Piot to its Board as Independent Director expresspharma
January 22, 2021
Professor Piot is the Director of the London School of Hygiene & Tropical Medicine and the Handa Professor of Global Health.
Abu Dhabi firm, ADQ invests Rs 555 crores in Biocon Biologics expresspharma
January 11, 2021
Biocon Biologics had raised over $255 million from global investors from Jan to Nov 2020.
USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan expresspharma
December 28, 2020
To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the standard review process.
Biocon Biologics signs MoU with CSSC in Tanzania for Mission 10 cents, affordable insulins programme expresspharma
December 16, 2020
Biocon Biologics, a subsidiary of Biocon, in continuation of its Mission 10 cents affordable insulins program for low- and middle-income countries (LMICs), has signed a Memorandum of Understanding (MoU) with the Christian Social Services Commission ...

Previous page 1 2 Next page